Daljit Singh Aurora - 12 Sep 2024 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
Chief Strategy Officer
Signature
/s/ Joshua Pinto, as Attorney-in-Fact for Daljit Singh Aurora
Issuer symbol
NMRA
Transactions as of
12 Sep 2024
Net transactions value
$0
Form type
4
Filing time
13 Sep 2024, 17:22:10 UTC
Previous filing
24 Apr 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NMRA Common Stock 97,500 12 Sep 2024 Direct
holding NMRA Common Stock 114,703 12 Sep 2024 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NMRA Stock Option (Right to Buy) Gift $0 -137,538 -77% $0.000000 40,890 12 Sep 2024 Common Stock 137,538 $4.24 Direct F2, F3
transaction NMRA Stock Option (Right to Buy) Gift $0 +137,538 $0.000000 137,538 12 Sep 2024 Common Stock 137,538 $4.24 See footnote F1, F2
transaction NMRA Stock Option (Right to Buy) Gift $0 -136,210 -40% $0.000000 207,901 12 Sep 2024 Common Stock 136,210 $6.51 Direct F2, F4
transaction NMRA Stock Option (Right to Buy) Gift $0 +136,210 $0.000000 136,210 12 Sep 2024 Common Stock 136,210 $6.51 See footnote F1, F2
transaction NMRA Stock Option (Right to Buy) Gift $0 -29,737 -29% $0.000000 72,221 12 Sep 2024 Common Stock 29,737 $6.36 Direct F2, F5
transaction NMRA Stock Option (Right to Buy) Gift $0 +29,737 $0.000000 29,737 12 Sep 2024 Common Stock 29,737 $6.36 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Aurora Family Trust.
F2 Represents fully vested stock options transferred pursuant to an option transfer agreement dated September 12, 2024 between the Reporting Person and Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries.
F3 25% of the shares subject to the option vest on the first anniversary measured from August 2, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F4 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F5 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.